Uploaded July 2026 | Updated September 2026, 3 days ago
Could we one day prevent type 1 diabetes?
In this episode of Diabetes Insights, Elizabeth Robertson, Director of Research and Clinical at Diabetes UK, and Rachel Connor, Director of Research Partnerships at Breakthrough T1D, discuss why prevention has become one of the most exciting areas in diabetes research.
They explain how immunotherapies are already delaying the onset of type 1 diabetes in some people, why early screening programmes such as the ELSA study are so important, and how advances in stem cell-derived beta cell therapies could transform treatment in the future.
The conversation also highlights the critical role charities play in funding research, building international collaborations, supporting clinical trials, and working with policymakers to ensure scientific breakthroughs reach people living with diabetes.
Subscribe for more interviews from EASD TV featuring the latest advances in diabetes research and care.
Could we one day prevent type 1 diabetes?
In this episode of Diabetes Insights, Elizabeth Robertson, Director of Research and Clinical at Diabetes UK, and Rachel Connor, Director of Research Partnerships at Breakthrough T1D, discuss why prevention has become one of the most exciting areas in diabetes research.
They explain how immunotherapies are already delaying the onset of type 1 diabetes in some people, why early screening programmes such as the ELSA study are so important, and how advances in stem cell-derived beta cell therapies could transform treatment in the future.
The conversation also highlights the critical role charities play in funding research, building international collaborations, supporting clinical trials, and working with policymakers to ensure scientific breakthroughs reach people living with diabetes.
Subscribe for more interviews from EASD TV featuring the latest advances in diabetes research and care.
